Healthcare Capital Corp.
HCCC
NASDAQ Global Select12.74
USD
+1.24
- -
CIK
0001676580
ISIN
US42228C1190
Return %
Stock
S&P500
1Y
- -
26.84
3Y
- -
77.03
5Y
26.14
80.55
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- William Johns
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 301 North Market Street Wilmington DE United States of America 19801
- IPO Date
- Mar 8, 2021
- CIK
- 0001676580
- Website
- healthcarecapitalcorp.com
- Similar Companies
- Business
- Healthcare Capital Corp. (Nasdaq: HCCC) operates as a blank check company, or special purpose acquisition company (SPAC), focused on the healthcare sector; it seeks to effect mergers, capital stock exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations with one or more healthcare businesses, particularly innovative enterprises addressing global healthcare market changes accelerated by the pandemic. The company offers no specific products or services beyond its SPAC structure for providing capital, expertise, and guidance to transition private healthcare companies to public ownership. Founded in 2020 and headquartered in Wilmington, Delaware, it targets opportunities in digital health, technology-enabled solutions, and other healthcare segments through its management team's industry relationships, venture capital networks, and operational experience. In a major transaction completed in March 2022, Healthcare Capital Corp. merged with Alpha Tau Medical Ltd. in a reverse merger, through which Alpha Tau became publicly traded under the ticker DRTS on Nasdaq, valuing Alpha Tau at an implied pre-money equity value of approximately $600 million and providing up to $367 million in gross proceeds including PIPE financing; post-merger, HCCC shares continue trading on Nasdaq as of late 2025 with a market capitalization around $300 million. The company maintains its Nasdaq listing under HCCC amid ongoing market activity, with no further publicly reported acquisitions, funding rounds, or strategic shifts in the last 1-2 years.
INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Inspired Healthcare Capital (IHC) Investors to Contact the Firm
Altamirano PLLC Issues Investor Notice on Inspired Healthcare Capital (IHC) Chapter 11 Bankruptcy Filing
Altamirano PLLC Issues Notice to Inspired Healthcare Capital (IHC) Investors on Recovery Options
Revival Healthcare Capital Announces Strategic Partnership to Accelerate External Innovation in Robotics With up to $458 Million Joint Investment With Olympus Into Co-Founded New Company Swan EndoSurgical
Affini-T Therapeutics Appoints Healthcare Capital Markets Veteran Kathy Bergsteinsson, MBA, as Chief Financial Officer